Services

Listings
  • Anti-CD19 (B496)-MCC-DM1 ADC

    Anti-CD19 (B496)-MCC-DM1 ADC

    Drug Development Shirley (New York) November 11, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD19 monoclonal antibody (B496) conjugated via a MCC linker to DM1. The DM1 is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cel...

  • Anti-CD19 (B496)-SPP-DM1 ADC

    Anti-CD19 (B496)-SPP-DM1 ADC

    Drug Development Shirley (New York) November 11, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD19 monoclonal antibody (B496) conjugated via a SPP linker to DM1. The DM1 is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cel...

  • Anti-CD19 (MDX1435)-VC-duocarmycin ADC

    Anti-CD19 (MDX1435)-VC-duocarmycin ADC

    Drug Development Shirley (New York) November 11, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD19 monoclonal antibody (MDX1435) conjugated via a VC linker to duocarmycin. The duocarmycin is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytos...

  • Anti-CD19 (clone huB4)-SMCC-DM1 ADC

    Anti-CD19 (clone huB4)-SMCC-DM1 ADC

    Drug Development Shirley (New York) November 11, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD19 monoclonal antibody (clone huB4) conjugated via a SMCC linker to DM1. The DM1 is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within ...

  • Anti-CD19 (clone huB4)-Mc-MMAF ADC

    Anti-CD19 (clone huB4)-Mc-MMAF ADC

    Drug Development Shirley (New York) November 11, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD19 monoclonal antibody (clone huB4) conjugated via a MC linker to MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within ...

  • Anti-CD19 (clone huB4)-SPDB-DM4 ADC

    Anti-CD19 (clone huB4)-SPDB-DM4 ADC

    Drug Development Shirley (New York) November 11, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD19 monoclonal antibody (clone hBU12) conjugated via a SPDB linker to a DM4. The DM4 is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. With...

  • Anti-CD19 (clone hBU12)-Mc-MMAE ADC

    Anti-CD19 (clone hBU12)-Mc-MMAE ADC

    Drug Development Shirley (New York) November 11, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD19 monoclonal antibody (clone hBU12) conjugated via a Mc linker to a MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. With...

  • Anti-CD19 (clone hBU12)-Mc-MMAF ADC

    Anti-CD19 (clone hBU12)-Mc-MMAF ADC

    Drug Development Shirley (New York) November 11, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD19 monoclonal antibody (clone hBU12) conjugated via a Mc linker to a MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. With...

  • Anti-CD19 (clone BU12)-Mc-MMAF ADC

    Anti-CD19 (clone BU12)-Mc-MMAF ADC

    Drug Development Shirley (New York) November 11, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD19 monoclonal antibody (clone BU12) conjugated via a Mc linker to MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within ...

  • Anti-CD19 (clone hBU12)-vc-PAB-MMAE ADC

    Anti-CD19 (clone hBU12)-vc-PAB-MMAE ADC

    Drug Development Shirley (New York) November 11, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD19 monoclonal antibody conjugated (clone hBU12) via a vc-PAB linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Wi...

  • Anti-CD180 (MHR73-11)-Mc-MMAF ADC

    Anti-CD180 (MHR73-11)-Mc-MMAF ADC

    Drug Development Shirley (New York) November 11, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD180 monoclonal antibody (MHR73-11) conjugated via a Mc linker to MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within t...

  • Anti-CD180 (MHR73-11)-Mc-VC-PABC-MMAE ADC

    Anti-CD180 (MHR73-11)-Mc-VC-PABC-MMAE ADC

    Drug Development Shirley (New York) November 11, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD180 monoclonal antibody (MHR73-11) conjugated via a Mc-VC-PABC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. ...